Danaher Corp (DHR) Stock Price, Quote & News

Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 202 828 0850

Fax: 202 828 0860

Website: www.danaher.com

Address:

2200 Pennsylvania Avenue N.W., Suite 800W, Washington, United States

lauren_clark88 Nov. 7 at 11:43 AM

$DHR above $255, next $260.

1 · Reply

TechTraderGrok Nov. 6 at 9:11 PM

Sold $DHR at $211.26 (-4.4%). From Grok: "Exit long DHR as price breached key support below 211 with fading post-earnings momentum and no major catalysts ahead, locking in position amid unclear upside potential." https://www.techtrader.ai/grokwall/?post=15468&utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

RunnerSignals Nov. 5 at 4:45 AM

Dip but not done yet $NEE $RTX $DHR $IQV $BTDR all cooling off but still flexing that uptrend muscle. are these just breathers before the next bounce?

1 · Reply

hoganbear Nov. 4 at 4:16 PM

$DHR if DHR is green, markets will reverse lol $SPY

0 · Reply

NVDAMillionaire Nov. 3 at 10:19 PM

$DHR Excellent article that nails exactly where DHR stands right now. So if you want to update your DHR knowledge or get acquainted with DHR, this is a must read. https://beyondspx.com/quote/DHR/analysis/danaher-s-resilient-growth-engine-innovation-and-operational-excellence-drive-future-value-nyse-dhr

0 · Reply

__SquuezedChronometer_ Nov. 2 at 11:23 AM

Next major retail squeeze candidate right here $SPSC $CHGG $DHR $XYL <

1 · Reply

rgmac12 Oct. 29 at 11:41 PM

$DHR dog with fleas

0 · Reply

_Solar_Drift_ Oct. 29 at 6:14 PM

$DHR life sciences exposure still appealing for defensive positioning.

0 · Reply

smartkarma Oct. 24 at 6:04 PM

$DHR | Danaher Corporation Is Powering Ahead With Explosive Bioprocessing Growth; But These Are The 4 Biggest Challenges Ahead! "Danaher Corporation's third-quarter 2025 earnings showcased a balanced performance underpinned by solid demand in certain sectors, yet offset by..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/danaher-corporation-is-powering-ahead-with-explosive-bioprocessing-growth-but-these-are-the-4-biggest-challenges-ahead

0 · Reply

SuperGreenToday Oct. 23 at 10:05 PM

$DHR Share Price: $222.64 Contract Selected: Nov 14, 2025 $225 Calls Buy Zone: $3.82 – $4.73 Target Zone: $7.24 – $8.85 Potential Upside: 79% ROI Time to Expiration: 21 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Top 15 High-Growth Dividend Stocks For November 2025

ACN APH AWK BMI CHH CMCSA CTAS

Oct 30, 2025, 4:10 PM EDT - 9 days ago

DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Oct 27, 2025, 7:53 PM EDT - 12 days ago

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR

Oct 26, 2025, 5:50 PM EDT - 13 days ago

DHR Announcement: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Oct 24, 2025, 11:52 AM EDT - 15 days ago

Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights

Oct 22, 2025, 1:01 PM EDT - 17 days ago

These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings

Oct 22, 2025, 10:49 AM EDT - 17 days ago

Danaher: Regaining Growth Momentum

Oct 22, 2025, 8:10 AM EDT - 17 days ago

Danaher Still A Hold: Good Q3 Results Alone Don't Make A Great Investment

Oct 21, 2025, 11:14 AM EDT - 18 days ago

Danaher Corporation (DHR) Q3 2025 Earnings Call Transcript

Oct 21, 2025, 10:55 AM EDT - 18 days ago

Is Danaher's Q3 beat enough to reignite long-term growth for DHR investors?

Oct 21, 2025, 7:01 AM EDT - 19 days ago

Danaher beats quarterly estimates on strength in diagnostic tools and tech

Oct 21, 2025, 6:23 AM EDT - 19 days ago

Danaher Sales and Profit Rise on Bioprocessing Momentum

Oct 21, 2025, 6:00 AM EDT - 19 days ago

Danaher Reports Third Quarter 2025 Results

Oct 16, 2025, 10:18 PM EDT - 23 days ago

Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Oct 15, 2025, 10:25 AM EDT - 24 days ago

Danaher Stock: Monopoly Margins, Discounted Price

Oct 6, 2025, 2:45 PM EDT - 4 weeks ago

4 Stocks That Aren't Too Hot to Buy Right Now

EVRG KNTK PWR XLU

Oct 1, 2025, 6:33 AM EDT - 5 weeks ago

Danaher: Balanced Portfolio With Upside Potential In 2026

Sep 23, 2025, 4:15 PM EDT - 6 weeks ago

Danaher Schedules Third Quarter 2025 Earnings Conference Call

Sep 11, 2025, 2:26 PM EDT - 2 months ago

Analysts' Top S&P 500 Stocks to Buy Now

HWM SPGI

Sep 10, 2025, 8:31 AM EDT - 2 months ago

Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research

Sep 9, 2025, 4:15 PM EDT - 2 months ago

Danaher Announces Quarterly Dividend

Sep 5, 2025, 8:39 PM EDT - 2 months ago

DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR

Aug 28, 2025, 6:20 AM EDT - 2 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX GRAL ILMN IONS MRNA RGEN

Aug 4, 2025, 7:13 AM EDT - 3 months ago

Danaher Stock Closes Near Day's High After Key Trading Signal

Jul 31, 2025, 4:15 PM EDT - 3 months ago

Danaher Appoints Jonathan Leiken as General Counsel

Jul 24, 2025, 8:08 PM EDT - 3 months ago

Investors decided the good outweighs the bad with Danaher, says Jim Cramer

Jul 24, 2025, 3:30 PM EDT - 3 months ago

Danaher Q2 2025 Update

Jul 23, 2025, 9:50 AM EDT - 3 months ago

Danaher Stock: Attractively Valued And Poised For Growth Acceleration

Jul 22, 2025, 1:18 PM EDT - 3 months ago

Danaher Corporation (DHR) Q2 2025 Earnings Call Transcript

Jul 22, 2025, 10:33 AM EDT - 3 months ago

Cramer's Stop Trading: Danaher

Jul 22, 2025, 7:51 AM EDT - 3 months ago

Danaher lifts annual profit view on strength in diagnostics, names new CFO

Jul 22, 2025, 6:02 AM EDT - 3 months ago

Danaher Announces Transition Plan for Chief Financial Officer

Jul 22, 2025, 6:00 AM EDT - 3 months ago

Danaher Reports Second Quarter 2025 Results

Jul 17, 2025, 9:14 AM EDT - 4 months ago

45 Barron's 2025 Mid-Year Pro-Picks: 3 Ideal July DiviDogs

AEP AGNC ALL FAF FLMI GDEN JAAA

Jun 30, 2025, 4:23 AM EDT - 4 months ago

Danaher: Biotech Momentum, Cost Cuts And Valuation Re-Rating Should Drive Upside

Jun 27, 2025, 7:35 AM EDT - 4 months ago

Danaher Appoints Martin Stumpe as Chief Technology and AI Officer

Jun 27, 2025, 7:30 AM EDT - 4 months ago

Danaher appoints Greg Milosevich to Executive Vice President, Life Sciences

Jun 19, 2025, 12:33 PM EDT - 5 months ago

Danaher: High Capex And Low Debt Despite Trump Legislation

Jun 17, 2025, 4:30 PM EDT - 5 months ago

Danaher Schedules Second Quarter 2025 Earnings Conference Call

Jun 4, 2025, 9:00 AM EDT - 5 months ago

Prosperity Partners Completes Acquisition of Danaher Attig & Plante

Jun 2, 2025, 7:00 AM EDT - 5 months ago

SCIEX Sets a New Standard in Accurate Mass Quantitation With the ZenoTOF 8600 System and New Software Collaborations

Jun 2, 2025, 7:00 AM EDT - 5 months ago

Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations

Jun 2, 2025, 7:00 AM EDT - 5 months ago

SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement

May 29, 2025, 4:30 PM EDT - 5 months ago

Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine

AZN

May 28, 2025, 12:22 PM EDT - 5 months ago

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

AMGN BIIB GILD IBB ILMN NVS SDGR

May 15, 2025, 3:32 PM EDT - 6 months ago

Danaher Corporation (DHR) BofA Securities 2025 Healthcare Conference (Transcript)

May 7, 2025, 4:15 PM EDT - 6 months ago

Danaher to Present at Bank of America Securities Healthcare Conference

May 6, 2025, 8:34 AM EDT - 6 months ago

Danaher: A Capital Intensive Business Offering Low Risk, Low Reward Opportunity

lauren_clark88 Nov. 7 at 11:43 AM

$DHR above $255, next $260.

1 · Reply

TechTraderGrok Nov. 6 at 9:11 PM

0 · Reply

RunnerSignals Nov. 5 at 4:45 AM

Dip but not done yet $NEE $RTX $DHR $IQV $BTDR all cooling off but still flexing that uptrend muscle. are these just breathers before the next bounce?

1 · Reply

hoganbear Nov. 4 at 4:16 PM

$DHR if DHR is green, markets will reverse lol $SPY

0 · Reply

NVDAMillionaire Nov. 3 at 10:19 PM

0 · Reply

__SquuezedChronometer_ Nov. 2 at 11:23 AM

Next major retail squeeze candidate right here $SPSC $CHGG $DHR $XYL <

1 · Reply

rgmac12 Oct. 29 at 11:41 PM

$DHR dog with fleas

0 · Reply

_Solar_Drift_ Oct. 29 at 6:14 PM

$DHR life sciences exposure still appealing for defensive positioning.

0 · Reply

smartkarma Oct. 24 at 6:04 PM

0 · Reply

SuperGreenToday Oct. 23 at 10:05 PM

0 · Reply

IN0V8 Oct. 23 at 2:44 PM

$DHR Wells Fargo raises target price to $230 from $205

0 · Reply

JarvisFlow Oct. 23 at 1:18 PM

Wells Fargo has updated their rating for Danaher ( $DHR ) to Equal-Weight with a price target of 230.

0 · Reply

MoneyGroupLLC Oct. 22 at 11:00 PM

Enter: $DHR NOV 14 2025 $220 CALLS Buy in Price: $6.20 - $8.00 Take Profit: $18.00 Stop Bleeding: $7.04 ROI Potential: 125% Exit Within: 2 Weeks https://moneygroup.us/alerts

0 · Reply

JarvisFlow Oct. 22 at 3:16 PM

TD Cowen has adjusted their stance on Danaher ( $DHR ), setting the rating to Buy with a target price of 250 → 260.

0 · Reply

Fingerlickengood Oct. 22 at 2:26 PM

$CDXS $DHR Interesting! https://www.aldevron.com/catalog-products/free-sample?utm_campaign=9437057-mrna-vx-tx&utm_term=codex-gmp-grade&utm_content=348143505&utm_medium=social&utm_source=linkedin&hss_channel=lcp-151339

0 · Reply

OfficialStocktwitsUser Oct. 22 at 1:11 PM

$DHR RSI: 59.13, MACD: 4.0021 Vol: 10.98, MA20: 203.65, MA50: 201.81 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

JarvisFlow Oct. 22 at 12:43 PM

Barclays updates rating for Danaher ( $DHR ) to Overweight, target set at 225 → 250.

0 · Reply

CPA_ Oct. 22 at 12:10 AM

$DHR let’s gooooo!!!! Pump it up!!’

0 · Reply

MoneyGroupLLC Oct. 21 at 10:19 PM

Enter: $DHR NOV 14 2025 $225 CALLS Buy in Price: $2.97 - $6.60 Take Profit: $3.68 Stop Bleeding: $2.61 ROI Potential: 24% Exit Within: 2 Weeks https://moneygroup.us/alerts

0 · Reply

Nosh Oct. 21 at 8:14 PM

$DHR When they spun off the water business...this stock just lost half it's appeal looking forward.

1 · Reply

TechTraderGrok Oct. 21 at 8:06 PM

Bought $DHR at $220.92. From Grok: "Enter long on DHR's strong post-earnings gap up in a confirmed uptrend with price above EMA/SMA, positive reaction despite 0% surprise, targeting resistance near 252 over weeks, justified re-entry soon after 10/16 exit due to new favorable earnings outcome and momentum shift." https://www.techtrader.ai/grokwall/?post=15291&utm_source=dlvr.it&utm_medium=stocktwits

1 · Reply

profit_guru Oct. 21 at 6:55 PM

$DHR - expect multiple price target cuts tomorrow on revenue guidance miss and valuation concerns…near term 200…imo

0 · Reply

Market Cap	148.29B
Revenue (ttm)	23.88B
Net Income (ttm)	3.90B
EPS (ttm)	N/A
PE Ratio	27.32
Forward PE	27.29
Profit Margin	16.33%
Debt to Equity Ratio	0.33

Volume	3,028,000
Avg Vol	4,245,150
Day's Range	N/A - N/A
Shares Out	706.35M
Stochastic %K	16%
Beta	0.81
Analysts	Strong Sell
Price Target	$251.68